|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Cash flows from operating activities | |||||
| Profit before taxation | |||||
| Adjustments to reconcile net income to cash flows from operations: | |||||
| Depreciation and amortization | |||||
| Investment income and exchange variation of financial instruments at fair value through profit or loss | |||||
| Net foreign exchange on liabilities at amortized cost | |||||
| Interest expense on loans and obligations | |||||
| Gain/loss on remeasurement of contingent consideration | |||||
| Allowance for expected credit loss | |||||
| Net profit/(loss) of investments accounted for using the equity method | |||||
| Share based payments | |||||
| Financial result on lease agreements | |||||
| Other adjustments | |||||
| Adjustments To Reconcile Profit Loss Other Than Changes In Working Capital | |||||
| Changes in assets and liabilities | |||||
| Accounts receivables | |||||
| Taxes recoverable | |||||
| Other assets | |||||
| Trade payables | |||||
| Accounts payable | |||||
| Labor and social security obligations | |||||
| Taxes and contributions payable | |||||
| Purchases of financial instruments related to retirements plans | |||||
| Contribution for retirements plans | |||||
| Increase Decrease In Working Capital | |||||
| Cash generated from operations | |||||
| Income tax paid | |||||
| Net cash inflow from operating activities | |||||
| Cash flows from investing activities | |||||
| Payment for acquisition of subsidiaries | |||||
| Cash and cash equivalent increased from business combination | |||||
| Acquisition of a subsidiary, net of cash acquired | |||||
| Purchases of property and equipment and additions to intangible assets | |||||
| Purchase and sales of financial instruments at amortized cost | |||||
| Purchase of financial instruments at fair value through profit or loss | |||||
| Sales of financial instruments at fair value through profit or loss | |||||
| Dividends received from joint ventures investments | |||||
| Capital increase in joint ventures | |||||
| Net cash (outflow) from investing activities | |||||
| Cash flows from financing activities | |||||
| Proceeds from the issuance of shares/quotas | |||||
| Capital increase of non-controlling interests in subsidiaries | |||||
| Interest payments of loans and obligations | |||||
| Principal payments of loans and obligations | |||||
| Transactions costs paid | |||||
| Treasury shares acquisition paid, net of treasury shares sold | |||||
| Lease payments, net of sublease received | |||||
| Loans and obligations acquisitions | |||||
| Proceeds from loans and obligations | |||||
| Issuance of convertible preferred shares | |||||
| Dividends paid | |||||
| Net cash (outflow) from financing activities | |||||
| Net increase in cash and cash equivalents | |||||
| Cash and cash equivalents at the beginning of the year | |||||
| Foreign exchange variation of cash and cash equivalents in subsidiary | |||||
| Cash and cash equivalents at the end of the year | |||||
Loading...